Phase 4 Lymphoma Clinical Trials
14 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–14 of 14 trials
Recruiting
Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Acute Lymphoblastic LeukemiaMixed Phenotype Acute LeukemiaLymphoblastic Lymphoma
St. Jude Children's Research Hospital850 enrolled3 locationsNCT06289673
Recruiting
Phase 4
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company279 enrolled36 locationsNCT06876662
Recruiting
Phase 4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Eli Lilly and Company787 enrolled38 locationsNCT06876649
Recruiting
Phase 4
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Hodgkin Lymphoma
Takeda124 enrolled11 locationsNCT06831370
Recruiting
Phase 4
Vaccine Responses in Patients With B Cell Malignancies
Lymphoma
National Heart, Lung, and Blood Institute (NHLBI)500 enrolled1 locationNCT05170399
Recruiting
Phase 4
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Beijing Tongren Hospital88 enrolled3 locationsNCT07355699
Recruiting
Phase 4
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
B-cell LymphomaHemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT07270835
Recruiting
Phase 4
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Acute Lymphoblastic LeukemiaNon-Hodgkin LymphomaAcute Myeloblastic Leukemia+1 more
Gadjah Mada University120 enrolled1 locationNCT07016165
Recruiting
Phase 4
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Lymphoma, Non-HodgkinStreptococcus PneumoniaeVaccine
Poitiers University Hospital160 enrolled7 locationsNCT04460235
Recruiting
Phase 4
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital8 enrolled1 locationNCT05806580
Recruiting
Phase 4
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
Lymphoma, B-Cell
Zhengzhou University20 enrolled1 locationNCT06609304
Recruiting
Phase 4
Clinical Study of OR for Second-line Treatment of Refractory MZL
OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma
Lixia Sheng39 enrolled3 locationsNCT06134284
Recruiting
Phase 4
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Lung CancerCarcinoma, Non-Small Cell LungDrug Monitoring+2 more
University Medical Center Groningen196 enrolled8 locationsNCT05525338
Recruiting
Phase 4
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Diffuse Large B Cell LymphomaPrimary CNS LymphomaBurkitt Lymphoma+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology300 enrolled1 locationNCT05518383